Cheryl M. Ethen

593 total citations
16 papers, 506 citations indexed

About

Cheryl M. Ethen is a scholar working on Molecular Biology, Organic Chemistry and Cell Biology. According to data from OpenAlex, Cheryl M. Ethen has authored 16 papers receiving a total of 506 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 5 papers in Organic Chemistry and 5 papers in Cell Biology. Recurrent topics in Cheryl M. Ethen's work include Glycosylation and Glycoproteins Research (8 papers), Carbohydrate Chemistry and Synthesis (5 papers) and Retinal Diseases and Treatments (4 papers). Cheryl M. Ethen is often cited by papers focused on Glycosylation and Glycoproteins Research (8 papers), Carbohydrate Chemistry and Synthesis (5 papers) and Retinal Diseases and Treatments (4 papers). Cheryl M. Ethen collaborates with scholars based in United States and Russia. Cheryl M. Ethen's co-authors include Deborah A. Ferrington, Xiao Feng, Timothy W. Olsen, Cavan Reilly, Zhengliang L. Wu, Miranda Machacek, W. Jiang, Weiping Jiang, Stacy A. Hussong and Rebecca J. Kapphahn and has published in prestigious journals such as Journal of Biological Chemistry, Biochemistry and Analytical Biochemistry.

In The Last Decade

Cheryl M. Ethen

16 papers receiving 504 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Cheryl M. Ethen United States 10 376 164 94 81 66 16 506
Tomoaki Uchiki United States 10 399 1.1× 38 0.2× 115 1.2× 22 0.3× 25 0.4× 11 596
Matthew J. Miller United States 9 208 0.6× 34 0.2× 66 0.7× 19 0.2× 22 0.3× 13 325
Charandeep Singh India 11 258 0.7× 50 0.3× 17 0.2× 31 0.4× 59 0.9× 23 401
Tuomas Ryhänen Finland 14 356 0.9× 282 1.7× 74 0.8× 9 0.1× 96 1.5× 19 629
Joan M. Spellman United States 14 93 0.2× 241 1.5× 23 0.2× 20 0.2× 112 1.7× 17 778
Dmitry S. Karpov Russia 14 495 1.3× 45 0.3× 63 0.7× 4 0.0× 24 0.4× 75 645
Thomas H. Charpentier United States 11 445 1.2× 42 0.3× 46 0.5× 8 0.1× 12 0.2× 20 500
Howard M. Jernigan United States 13 402 1.1× 43 0.3× 143 1.5× 20 0.2× 13 0.2× 37 507
Anthony W. Scotto United States 11 249 0.7× 36 0.2× 28 0.3× 7 0.1× 15 0.2× 15 353
Hetal Brahmbhatt United States 8 417 1.1× 11 0.1× 34 0.4× 20 0.2× 11 0.2× 17 563

Countries citing papers authored by Cheryl M. Ethen

Since Specialization
Citations

This map shows the geographic impact of Cheryl M. Ethen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cheryl M. Ethen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cheryl M. Ethen more than expected).

Fields of papers citing papers by Cheryl M. Ethen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cheryl M. Ethen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cheryl M. Ethen. The network helps show where Cheryl M. Ethen may publish in the future.

Co-authorship network of co-authors of Cheryl M. Ethen

This figure shows the co-authorship network connecting the top 25 collaborators of Cheryl M. Ethen. A scholar is included among the top collaborators of Cheryl M. Ethen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cheryl M. Ethen. Cheryl M. Ethen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Wu, Zhengliang L., et al.. (2016). Non-reducing end labeling of heparan sulfate via click chemistry and a high throughput ELISA assay for heparanase. Glycobiology. 27(6). cww130–cww130. 7 indexed citations
2.
Wu, Zhengliang L., Hui Zhou, Cheryl M. Ethen, & Vernon N. Reinhold. (2016). Core-6 fucose and the oligomerization of the 1918 pandemic influenza viral neuraminidase. Biochemical and Biophysical Research Communications. 473(2). 524–529. 6 indexed citations
3.
Thomas, Holly R., Cheryl M. Ethen, Zhengliang L. Wu, et al.. (2014). Inhibition of SULT4A1 Expression Induces Up-Regulation of Phototransduction Gene Expression in 72-Hour Postfertilization Zebrafish Larvae. Drug Metabolism and Disposition. 42(5). 947–953. 9 indexed citations
4.
Ethen, Cheryl M., et al.. (2014). Nonradioactive Glycosyltransferase and Sulfotransferase Assay to Study Glycosaminoglycan Biosynthesis. Methods in molecular biology. 1229. 431–441. 2 indexed citations
5.
Mao, Yang, Yu Huang, Jo Ann Buczek‐Thomas, et al.. (2014). A Liquid Chromatography-Mass Spectrometry-based Approach to Characterize the Substrate Specificity of Mammalian Heparanase. Journal of Biological Chemistry. 289(49). 34141–34151. 27 indexed citations
6.
Ethen, Cheryl M., et al.. (2012). Golgi-resident PAP-specific 3′-phosphatase-coupled sulfotransferase assays. Analytical Biochemistry. 423(1). 86–92. 12 indexed citations
7.
Wu, Zhengliang L., et al.. (2010). Detection of specific glycosaminoglycans and glycan epitopes by in vitro sulfation using recombinant sulfotransferases. Glycobiology. 21(5). 625–633. 7 indexed citations
8.
Wu, Zhengliang L., et al.. (2010). A versatile polyacrylamide gel electrophoresis based sulfotransferase assay. BMC Biotechnology. 10(1). 11–11. 12 indexed citations
9.
Wu, Zhengliang L., et al.. (2010). Universal phosphatase-coupled glycosyltransferase assay. Glycobiology. 21(6). 727–733. 84 indexed citations
10.
Wu, Zhengliang L., et al.. (2009). Active 1918 pandemic flu viral neuraminidase has distinct N-glycan profile and is resistant to trypsin digestion. Biochemical and Biophysical Research Communications. 379(3). 749–753. 32 indexed citations
11.
Ethen, Cheryl M., Cavan Reilly, Xiao Feng, Timothy W. Olsen, & Deborah A. Ferrington. (2007). Age-Related Macular Degeneration and Retinal Protein Modification by 4-Hydroxy-2-nonenal. Investigative Ophthalmology & Visual Science. 48(8). 3469–3469. 78 indexed citations
12.
Ethen, Cheryl M., Stacy A. Hussong, Cavan Reilly, et al.. (2007). Transformation of the proteasome with age‐related macular degeneration. FEBS Letters. 581(5). 885–890. 69 indexed citations
13.
Ethen, Cheryl M., Cavan Reilly, Xiao Feng, Timothy W. Olsen, & Deborah A. Ferrington. (2006). The Proteome of Central and Peripheral Retina with Progression of Age-Related Macular Degeneration. Investigative Ophthalmology & Visual Science. 47(6). 2280–2280. 83 indexed citations
14.
Ethen, Cheryl M., Xiao Feng, Timothy W. Olsen, & Deborah A. Ferrington. (2005). Declines in Arrestin and Rhodopsin in the Macula with Progression of Age-Related Macular Degeneration. Investigative Ophthalmology & Visual Science. 46(3). 769–769. 23 indexed citations
15.
Kapphahn, Rebecca J., Cheryl M. Ethen, Elizabeth A. Peters, LeeAnn Higgins, & Deborah A. Ferrington. (2003). Modified αA Crystallin in the Retina:  Altered Expression and Truncation with Aging. Biochemistry. 42(51). 15310–15325. 54 indexed citations
16.
Ferrington, Deborah A., Rebecca J. Kapphahn, Cheryl M. Ethen, L. A. Higgins, & Elizabeth A. Peters. (2003). Age-Related Posttranslational Modifications of Crystallins in Rat Retina. 44(13). 1601–1601. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026